Louis Chen
Stock Analyst at Cantor Fitzgerald
(n/a)
# 4,826
Out of 4,829 analysts
11
Total ratings
9.09%
Success rate
-63.32%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Louis Chen
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
CATX Perspective Therapeutics | Reiterates: Overweight | n/a | $2.51 | - | 8 | Sep 10, 2024 | |
THTX Theratechnologies | Reiterates: Overweight | $36 | $2.63 | +1,271.43% | 2 | Jul 13, 2023 | |
PCVX Vaxcyte | Reiterates: Overweight | $55 | $31.59 | +74.11% | 1 | Feb 24, 2022 |
Perspective Therapeutics
Sep 10, 2024
Reiterates: Overweight
Price Target: n/a
Current: $2.51
Upside: -
Theratechnologies
Jul 13, 2023
Reiterates: Overweight
Price Target: $36
Current: $2.63
Upside: +1,271.43%
Vaxcyte
Feb 24, 2022
Reiterates: Overweight
Price Target: $55
Current: $31.59
Upside: +74.11%